PITPNM3 and breast carcinoma: As the key functional receptor for CCL18, PITPNM3 is expressed primarily on the cell surface of tumor cells and it has been reported that TAM secreted CCL18 interacted with its receptor PITPNM3 to promote breast cancer metastasis and angiogenesis [16, 17].